Ophthalmic Devices Market Forecast 2014-2024
Future Prospects for Leading Companies

世界の眼科装置市場予測:眼科ビジョンケア装置、眼科診断・モニタリング装置、眼科手術装置

◆タイトル:Ophthalmic Devices Market Forecast 2014-2024
Future Prospects for Leading Companies
◆商品コード:VISG409053
◆調査・発行会社:visiongain
◆発行日:2014年6月
◆ページ数:192
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single user licence(1名使用)GBP1,799 ⇒換算¥269,850見積依頼/購入/質問フォーム
Dept Licence(部署内共有可)GBP2,999 ⇒換算¥449,850見積依頼/購入/質問フォーム
Site Licence(同一国内社内共有可)GBP4,999 ⇒換算¥749,850見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"世界の眼科装置市場予測:眼科ビジョンケア装置、眼科診断・モニタリング装置、眼科手術装置"について調査・分析し、レポートサマリー、世界市場規模・市場予測、地域別市場分析、主要国別市場分析、市場環境分析、専門家の見解、結論などの情報をお届けいたします。

Ophthalmic devices – new study showing you trends, R&D progress, and predicted revenues
Where is the ophthalmic devices market heading? Visiongain’s brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.

Our 192-page report provides 142 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing medical device market.

Forecasts from 2014-2024 and other analyses show you commercial prospects
Besides revenue forecasting to 2024, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (SWOT and Porter’s Five Forces Analysis), company profiles and commercial developments. Read the full transcripts of 2 exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales:
- Professor Bernard Chang, Consultant Ophthalmologist, Spire Leeds Hospital
- Will Moore, CEO and President, IRIDEX

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, you see forecasts to 2024 for three submarkets and their respective segments:
• Diagnostic and monitoring
- Autorefractor/Keratometer
- OCT machines
- Fundus cameras
- Slit lamps
- Others
• Surgical
- Intraocular lenses
- Ophthalmic lasers
- Phacoemulsification devices
- Ophthalmic viscoelastic devices
- Others
• Vision care
- Daily disposables
- Others

Our investigation discusses what stimulates and restrains business. You will find dynamics of the industry and assess its potential sales, seeing devices and procedures likely to achieve the most success.

What are the prospects in the leading regions and countries?
In addition to analyses of the overall world market, you will discover individual revenue forecasts for 13 national markets to 2024:
• US
• Japan
• France
• Germany
• Italy
• Spain
• UK
• Rest of Europe
• Brazil
• Russia
• India
• China
• South Korea
• Mexico
• RoW

There will be growth in established medical devices markets and in developing countries. Our analyses show that India, Brazil, China, Russia and South Korea in particular, will continue to achieve high revenue growth to 2024. Developments worldwide in product approval and regulations will influence the market.

Leading companies and potential for market growth
Overall world revenue for ophthalmic devices will reach $16.29bn in 2014, our work forecasts. We predict steady revenue growth from 2014 to 2024. Rising demand for ophthalmic devices and expanding healthcare coverage in emerging economies will increase sales to 2024.

Our work shows you what organisations hold greatest potential. See profiles of 10 leading companies, including these:
• Alcon (Novartis)
• Abbott Medical Optics (Abbott)
• Bausch and Lomb (Valeant Pharmaceuticals)
• Johnson and Johnson Vision Care (Johnson and Johnson)
• Nidek
• Hoya Corporation
• STAAR Surgical
• Carl Zeiss AG Meditec
• Topcon Corporation
• Haag-Streit Holding AG

In general, a company profile gives you the following information:
• Discussion of a company’s activities and outlook
• Recent financial results
• Assessment of recent developments – mergers and acquisitions (M&A), new products, and collaborations, including alliances, partnerships and joint ventures

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the ophthalmic devices industry?
Our new report discusses issues and events affecting the ophthalmic devices market. You will find discussions, including qualitative analyses:
• A global aging population
• Increasing prevalence of eye disorders
• Increasing funds for R&D and clinical development
• Increasing sophistication of ophthalmic diagnostic devices
• Impact of the US medical device excise tax

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

【レポートの目次】

1. Report Overview
1.1 Global Ophthalmic Devices Market Overview
1.2 Global Ophthalmic Devices Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain

2. Introduction to the Ophthalmic Devices Market
2.1 The Eye: An Overview of Its Structure and Function
2.2 The Global Burden of Eye Disease
2.3The Diagnosis and Surgical Treatment for Eye Diseases
2.3.1Refractive errors (Myopia, Hyperopia or Astigmatism)
2.3.1.1 Lasik Eye Surgery (Laser In-Situ Keratomileusis)
2.3.1.2 Phakic Intraocular Surgery
2.3.1.3 Photorefractive keratectomy (PRK)
2.3.1.4 Conductive Keratoplasty (CK)
2.3.1.5 Refractive Lens Exchange (RLE)
2.3.2 Cataracts
2.3.2.1 Phacoemulsification and Intraocular Lens
2.3.2.2 Microincision Cataract Surgery (MICS)
2.3.3 Glaucoma
2.3.3.1 Diagnosis of Glaucoma
2.3.3.2 Glaucoma Surgical Treatment
2.3.4 Age-related Macular Degeneration (AMD)
2.3.4.1 Dry (non-exudative) AMD
2.3.4.1.1 Treatment for Dry AMD
2.3.4.2 Wet (exudative) AMD
2.3.4.3 Surgical Treatment of Wet AMD
2.3.4.3.1 Photodynamic Therapy
2.3.4.3.2 Laser Photocoagulation
2.3.4.3.3 Radiotherapy
2.3.4.3.4 Newer Types of Surgery
2.3.4.3.5 Wet AMD: Poor Outcomes with Surgical Procedures
2.3.5 Diabetic Retinopathy (DR)
2.3.5.1 Diagnosis of Diabetic Retinopathy
2.3.5.2 Treatment of Diabetic Retinopathy
2.3.6 Dry Eye Syndrome
2.3.6.1 Treatment of Dry Eye Syndrome
2.3.6.1.1 Punctal Occlusion
2.3.6.1.2 Salivary Gland Autotransplantation
2.4 Ophthalmic Devices
2.4.1 What are Ophthalmic Devices?
2.4.2 Devices: Classification
2.4.2.1 The US Medical Devices Classification System
2.4.2.2 The EU Medical Devices Classification System
2.4.3 Regulation of Ophthalmic Devices
2.4.3.1 The US Approval and Regulation System
2.4.3.2 The EU Approval and Regulation System
2.4.3.3 The Japanese Approval and Regulation System
2.5 Ophthalmic Devices: Market Segmentation
2.5.1 The Monitoring and Diagnostics Ophthalmic Devices Market
2.5.1.1 General Eye Health
2.5.1.2 Refractive Error Monitoring and Diagnostics Devices
2.5.1.3 Glaucoma Monitoring and Diagnostic Devices
2.5.2 The Surgical Ophthalmic Devices Market
2.5.2.1 Cataract Surgery Devices
2.5.2.2 Glaucoma Surgery Devices
2.5.2.3 Refractive Error Surgery Devices
2.5.2.4 Vitreoretinal Surgery Devices
2.5.3 The Vision Care Devices Market

3. The Ophthalmic Devices Market, 2014-2024
3.1 The Medical Devices Market Overview
3.1.1 The Medical Devices Market, 2013
3.1.2 The Medical Devices Market, 2014-2024
3.2 The Ophthalmic Devices Market by Submarket, 2013
3.3 The Ophthalmic Devices Market, 2014-2024

4. The Ophthalmic Vision Care Devices Market, 2014-2024
4.1 The Ophthalmic Vision Care Devices Market Overview
4.2 The Ophthalmic Vision Care Devices Market, 2014-2024
4.2.1 The Ophthalmic Vision Care Devices Market by Segment
4.2.1.1 The Ophthalmic Vision Care Devices Market by Segment, 2013
4.2.1.2 The Ophthalmic Vision Care Devices Market by Segment, 2014-2024
4.2.1.2.1 The Daily Disposable Contact Lenses Market, 2014-2024
4.2.1.2.2 The Other Contact Lenses Market, 2014-2024
4.3 Contact Lenses on the Market
4.4 The Contact Lenses Market: New Product Development and Product Pipeline
4.4.1 Clariti® 1 Day (Sauflon)
4.4.2 MyDay™ Daily Disposable Lenses (CooperVision)
4.4.3 1-DAY ACUVUE® TruEye® (Johnson & Johnson Vision Care)
4.4.4 Biotrue™ ONEday Contact Lenses (Bausch and Lomb)
4.4.5 Anti Microbial Contact Lenses (Brien Holden Vision Institute and School of
Optometry and Vision Science, University of New South Wales)
4.5 SWOT Analysis of the Vision Care Market, 2014-2024
4.5.1 Strengths
4.5.1.1 Silicone Hydrogels have Revolutionised Contact Lenses
4.5.1.2 Greater Use of Disposable Contact Lenses
4.5.2 Weaknesses
4.5.2.1 High Entry Barriers for New Entry Manufacturers
4.5.2.2 Fast Downward Pricing Pressure
4.5.2.3 Hygiene Issues
4.5.2.4 Greater Susceptibility to Global Recession
4.5.3 Opportunities
4.5.3.1 Growing Affluent Population in Emerging Economies
4.5.3.2 Contact Lenses Used as Diagnostic Tools
4.5.3.3 Sale of Cosmetic and Coloured Lenses
4.5.4 Threats
4.5.4.1 Growing Demand for Lasik Surgery

5. The Ophthalmic Diagnostics and Monitoring Devices Market, 2014-2024
5.1 The Ophthalmic Diagnostics and Monitoring Devices Market Overview
5.2 The Ophthalmic Diagnostics and Monitoring Devices Market, 2013
5.3 The Ophthalmic Diagnostics and Monitoring Devices Market by Segment, 2014-2024
5.4 The Autorefractor/Keratometer Market, 2014-2024
5.5 The Fundus Camera Market, 2014-2024
5.6 The Slit Lamp Market, 2014-2024
5.7 The OCT Machine Market, 2014-2024
5.7.1 Ophthalmic OCT Machine Products
5.8 The Other Ophthalmic Diagnostics and Monitoring Devices Market, 2014-2024
5.9 Diagnostic Pipeline
5.9.1 Diagnostics and Monitoring Contact Lenses
5.9.1.1 Sensimed (Triggerfish)
5.9.1.2 Pro-IOP eye pressure sensor (Implandata Ophthalmic Products GmbH)
5.9.1.3 Glucose Monitoring Contact Lens (Google)
5.10 SWOT Analysis of the Ophthalmic Diagnostic and Monitoring Devices Market, 2014-2024
5.10.1 Strengths
5.10.1.1 Increasing Sophistication of Ophthalmic Diagnostic Devices
5.10.2 Weaknesses
5.10.2.1 Shortage of Ophthalmic Device Providers
5.10.3 Opportunities
5.10.3.1 Ageing Population
5.10.3.2 Increasing Demand for Advanced Optical Coherence Tomography
Machines
5.10.3.3 Increasing Demand for Advanced Ophthalmic Diagnostic Devices in
Emerging Markets
5.10.4 Threats
5.10.4.1 Increasing Cost of Healthcare
5.10.4.2 US Medical Device Excise Tax

6. The Ophthalmic Surgical Devices Market, 2014-2024
6.1 The Ophthalmic Surgical Devices Market Overview
6.1.1 The Surgical Ophthalmic Devices Market, 2013
6.1.2 The Surgical Ophthalmic Devices Market, 2014-2024
6.2 The Intraocular Lenses Market, 2014-2024
6.2.1 Intraocular Lenses Products
6.2.2 Intraocular Lenses Product Pipeline
6.2.2.1 Smart IOL (Medennium)
6.2.2.2 NuLens Accommodating IOL (NuLens)
6.2.2.3 Flex Optic IOL (Quest Vision/AMO)
6.2.2.4 Zephyr (Anew Optics)
6.2.2.5 The FluidVision Lens (PowerVision)
6.2.2.6 Superior Accommodating IOL (HumanOptics)
6.2.2.7 KAMRA Vision (Acufocus)
6.3 The Ophthalmic Laser Market, 2014-2024
6.3.1 Laser System Products
6.3.1.1Refractive Lasers
6.3.1.2 STAR S4 IR™ Excimer Laser (Abbott Medical Optics)
6.3.1.3 WaveLight® Allegretto Wave® Eye-Q Laser (Alcon)
6.3.1.4 NIDEK Advanced Vision Excimer Laser System NAVEX Quest (Nidek)
6.3.1.5 TECHNOLAS® TENEO™ 317 Laser (Bausch and Lomb Technolas)
6.3.2 Cataract Lasers
6.3.2.1 The LenSx Laser (Alcon)
6.3.2.2 LENSAR Laser System (LENSAR)
6.3.2.3 Catalys Precision Laser System (Abbott Medical Optics)
6.3.2.4 VICTUS Femtosecond Laser Platform (Bausch and Lomb Technolas)
6.3.2.5 Lumenis Vision (InSight)
6.4 The Phacoemulsification Device Market, 2014-2024
6.5 The Ophthalmic Viscoelastic Device Market, 2014-2024
6.6 The Other Surgical Ophthalmic Devices Market, 2014-2024
6.7 Ophthalmic Drug Delivery Devices
6.7.1 Recent Approvals
6.7.1.1 Vitrasert® ganciclovir 4.5mg (Bausch + Lomb)
6.7.1.2 Retisert® fluocinolone acetonide (Bausch + Lomb)
6.7.1.3 Ozurdex® dexamethasone (Allergan)
6.7.1.4 Iluvien® fluocinolone acetonide (Alimera Sciences)
6.7.2 Novel Ocular Drug Delivery Platform Pipeline
6.7.2.1 ECT Platform (Neurotech Pharmaceuticals)
6.7.2.2 SynBiosys® Polymer Platform (InnoCore)
6.7.2.3 Hydrogel Technology Products (Ocular Therapeutix)
6.7.2.4 Helios Ocular (ForSight Vision5)
6.7.2.5 L-PPDS Drug Delivery System (Mati Therapeutics)
6.8 Microinvasive Glaucoma Surgery (MIGS)
6.8.1 MIGS Product Approvals
6.8.1.1 Trabectome (NeoMedix Corporation)
6.8.1.2 EX-PRESS Glaucoma Filtration Devices (Alcon)
6.8.1.3 iStent (Glaukos)
6.8.2 Stents in the Glaucoma Pipeline
6.8.2.1 CyPass Micro-Stent (Transcend Medical)
6.8.2.2 Hydrus (Ivantis)
6.8.2.3 XEN Gel Stent (Aquesys)
6.9 Other Ophthalmic Surgical Devices in Development
6.9.1 Argus II Retinal Implant (Second Sight)
6.9.2 Alpha IMS (Retina Implant AG)
6.10 SWOT Analysis of the Ophthalmic Surgical Devices Market, 2014-2024
6.10.1 Strengths
6.10.1.1 Highest Growing Submarket
6.10.1.2 Fast Development of IOL Technology
6.10.1.3 Increasingly Sophisticated Laser Surgery
6.10.2 Weaknesses
6.10.2.1 Extended FDA Timelines
6.10.2.2 Challenging Reimbursement Environment
6.10.3 Opportunities
6.10.3.1 Ageing Population
6.10.3.2 Rising Diabetes Epidemic
6.10.3.3 Large Pipeline of Products
6.10.4 Threats
6.10.4.1 Venture Capital Available to Support Early Stage Companies is
Trending Down
6.10.4.2 Pharmaceuticals Compete as Therapies for Ocular Diseases
6.10.4.3 US Medical Device Excise Tax

7. The Leading National Ophthalmic Devices Markets, 2014-2024
7.1 The Leading National Ophthalmic Devices Market, 2013
7.1.1 The Leading National Ophthalmic Devices Market Forecast, 2014-2024
7.2 The US Ophthalmic Devices Market Forecast, 2014-2024
7.3 The European Ophthalmic Devices Market, 2013
7.3.1 The European Ophthalmic Devices Market Forecast, 2014-2024
7.3.1.1 The German Ophthalmic Devices Market Forecast, 2014-2024
7.3.1.2 The French Ophthalmic Devices Market Forecast, 2014-2024
7.3.1.3 The Italian Ophthalmic Devices Market Forecast, 2014-2024
7.3.1.4 The Spanish Ophthalmic Devices Market Forecast, 2014-2024
7.3.1.5 The UK Ophthalmic Devices Market Forecast, 2014-2024
7.4 The Japanese Ophthalmic Devices Market Forecast, 2014-2024
7.5 The Brazilian Ophthalmic Devices Market Forecast, 2014-2024
7.6 The Russian Ophthalmic Devices Market Forecast, 2014-2024
7.7 The Indian Ophthalmic Devices Market Forecast, 2014-2024
7.8 The Chinese Ophthalmic Devices Market Forecast, 2014-2024
7.9 The South Korean Ophthalmic Devices Market Forecast, 2014-2024
7.10 The Mexican Ophthalmic Devices Market Forecast, 2014-2024

8. The Leading Ophthalmic Devices Companies, 2014-2024
8.1 Alcon (Acquired by Novartis)
8.1.1 Recent Financial Performance, 2012-2013
8.1.1.1 Surgical Segment: Financial Performance, 2012-2013
8.1.1.2 Vision Care Segment: Financial Performance, 2012-2013
8.1.2 Product Line
8.1.2.1 Surgical Products
8.1.2.1.1 The CENTURION® Vision System
8.1.2.1.2 LenSx® Laser
8.1.2.1.3 The WaveLight® Refractive Suite
8.1.2.1.4 The WaveLight® Allegretto Wave® Eye-Q Laser
8.1.2.1.5 ACRYSOF® IOLS
8.1.2.1.6 The EX-PRESS® Glaucoma Filtration Device
8.1.2.2 Vision Care Products
8.1.2.2.1 AIR OPTIX®
8.1.2.2.2 FOCUS DAILIES
8.1.3 Mergers and Acquisitions
8.1.3.1 Novartis Acquisition of Alcon
8.1.3.2 Acquisition of Endure Medical Systems
8.1.3.3 Acquisition of SensoMotoric Instruments GmbH (SMI) – Ophthalmic
Division
8.1.3.4 Acquisition of LenSx Lasers
8.1.4 Jobs Losses
8.2 Abbott Medical Optics (AMO)
8.2.1 AMO Financial Performance, 2012-2013
8.2.2 AMO Product Portfolio
8.2.3 Mergers and Acquisitions
8.2.3.1 Abbott’s Acquisition of Advanced Medical Optics
8.2.3.2 Acquisition of OptiMedica
8.2.3.3 Acquisition of VISX
8.3 Bausch and Lomb (B+L) (acquired by Valeant)
8.3.1 Bausch and Lomb Financial Performance, 2008-2012
8.3.1.1 Bausch and Lomb Financial Performance by Segment, 2010-2012
8.3.2 Mergers and Acquisitions
8.3.2.1 Acquisition of Laboratorio Pförtner Cornealent SACIF
8.3.2.2 Valeant’s Acquisition of Bausch and Lomb
8.3.2.3 Acquisition of Technolas Perfect Vision GmbH
8.3.2.4 Acquisition of Eyeonics
8.3.3 Bausch and Lomb’s Price Fixing in China
8.4 Johnson & Johnson Vision Care
8.4.1 Johnson and Johnson Vision Care Financial Performance, 2013
8.4.1.1 Johnson and Johnson Vision Care Financial Performance, 2011- 2013
8.4.2 J&J Vision Care Product Portfolio
8.4.3 Vistakon Expansion of Manufacturing Facilities
8.4.3.1 Johnson and Johnson Fined for Price Fixing Contact Lens in China
8.5 Nidek
8.5.1 Nidek Financial Performance, 2008-2012
8.5.2 Leading Product lines
8.5.2.1 Surgical Systems
8.5.2.2 Intraocular Lens
8.5.2.3 Ophthalmic Lasers
8.5.2.4 Refractive Surgery Systems
8.5.2.5 Diagnostic Equipment
8.6 Hoya Corporation
8.6.1 Hoya Financial Performance, 2007-2013
8.6.1.1 Hoya Financial Performance by Business Segment, 2013
8.6.2 Hoya IOL Product Line
8.7 STAAR Surgical (STAAR)
8.7.1 STAAR Surgical Financial Performance, 2009-2013
8.7.2 STAAR: Revenue by Region, 2013
8.7.3 STAAR: Revenue by Segment, 2011-2013
8.7.4 STAAR: Product Line
8.7.4.1 Intracollamer Lenses
8.7.4.2 Intraocular Lenses
8.8 Carl Zeiss AG Meditec
8.8.1 Carl Zeiss Meditec Revenue Financial Performance, 2012-2013
8.8.2 Carl Zeiss Meditec Revenue by Business Unit, 2012-2013
8.8.3 Carl Zeiss Meditec Revenue by Region, 2013
8.8.4 Carl Zeiss Meditec Product Line
8.8.5 Mergers and Acquisitions
8.8.5.1 Acquisition of Aaren Scientific
8.9 TopCon
8.9.1 TopCon: Revenue by Company, 2013
8.9.2 TopCon: Major Ophthalmic Devices Products
8.9.2.1 3D OCT-2000 Spectral Domain OCT
8.9.2.2 Other Major Products
8.9.3 Mergers and Acquisitions
8.9.3.1 Acquisition of Optimedica’s Retina and Glaucoma Business
8.10 Haag-Streit Holding AG
8.10.1 Haag-Streit Holding AG Product Line

9. Qualitative Analysis of the Ophthalmic Devices Market 2014-2024
9.1 Porter’s Five Forces Analysis of the Ophthalmic Devices Market
9.1.1 Rivalry Among Competitors [High]
9.1.2 Threat of New Entrants [Medium]
9.1.3 Power of Suppliers [Low]
9.1.4 Power of Buyers [High]
9.1.5 Threat of Substitutes (High)

10. Expert Opinion
10.1 Professor Bernard Chang, Consultant Ophthalmologist, Spire Leeds Hospital
10.1.1 The Evolution of Diagnostic and Surgical Ophthalmic Devices
10.1.2 The Needs for Advancement in Ophthalmic Therapy
10.1.3 Ophthalmic Diseases Indications and the Use of Surgery as Therapy
10.1.4 Reimbursement of Ophthalmic Devices
10.1.5 The Regulatory Concerns for Ophthalmic Devices
10.2 Will Moore, CEO and President, IRIDEX
10.2.1 M&A Increases in the Ophthalmic Devices Market
10.2.2 Iridex’s Business Strategy
10.2.3 Iridex’s Regional Sales Focus
10.2.4 High Revenue Generating Products
10.2.5 Iridex’s Pipeline Products

11. Conclusions
11.1 The World Ophthalmic Devices Market, 2013-2014
11.2 Leading Ophthalmic Devices Submarkets
11.3 World Ophthalmic Devices Market Forecast, 2014-2024
11.4 Leading Segments of the Ophthalmic Devices Submarkets



List of Tables
Table 2.1 Segments and Definitions of the Ophthalmic Market
Table 2.2 ICD 10 Classification of Visual Impairment, 2010
Table 2.3 The US Classification of Medical Devices
Table 2.4 The EU Classification of Medical Devices
Table 3.1 The Global Medical Devices Market: Revenue ($bn), Market Share (%) by Sector, 2013
Table 3.2 The Global Medical Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 3.3 Submarkets of the Ophthalmic Devices Market: Revenue ($bn), Market Share (%),
2013
Table 3.4 The Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.1 The Vision Care Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.2 The Ophthalmic Vision Care Devices Market: Revenue ($bn), Market Share (%) by Segment, 2013
Table 4.3 The Ophthalmic Vision Care Devices Market: Revenue ($bn), AGR (%), CAGR (%) by Segment, 2013-2024
Table 4.4 The Daily Disposable Contact Lenses Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.5 The Other Contact Lenses Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.6 Leading Silicone Hydrogel Contact Lenses Products in the Market, 2014
Table 4.7 SWOT Analysis of the Vision Care Devices Market , 2013-2024
Table 5.1 The Ophthalmic Diagnostics and Monitoring Market: Revenue ($bn), Market Shares (%) by Segment, 2013
Table 5.2 The Ophthalmic Diagnostics and Monitoring Market: Revenue ($bn), AGR (%),CAGR (%) by Segment, 2013-2024
Table 5.3 The Autorefractor/Keratometer Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 5.4 The Fundus Camera Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 5.5 The Slit Lamp Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 5.6 The OCT Machine Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 5.7 Leading Ophthalmic OCT Machines in the Market, 2014
Table 5.8 The Other Ophthalmic Diagnostics and Monitoring Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 5.9 SWOT Analysis of the Ophthalmic Diagnostics and Monitoring Devices Market , 2013-2024
Table 6.1 The Ophthalmic Surgical Devices Market: Revenue ($bn), Market Share (%) by
Segment, 2013
Table 6.2 The Ophthalmic Surgical Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 6.3 The Intraocular Lenses Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 6.4 The Types of Premium IOLs on the Market, 2014
Table 6.5 The Ophthalmic Laser Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 6.6 The Phacoemulsification Device Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 6.7 The Ophthalmic Viscoelastic Device Market: Revenue ($bn), AGR (%), CAGR (%),
2013-2024
Table 6.8 The Other Ophthalmic Surgical Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 6.9 SWOT Analysis of the Ophthalmic Surgical Devices Market, 2013-2024
Table 7.1 The Ophthalmic Devices Market: Revenue ($bn), Market Share (%) by Region, 2013
Table 7.2 The Leading National Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.3 The US Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.4 The European Ophthalmic Devices Market: Revenue ($bn), Market Share (%) by
Country, 2013
Table 7.5 The European Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%) by Country, 2013-2024
Table 7.6 The German Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.7 The French Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.8 The Italian Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.9 The Spanish Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.10 The UK Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.11 The Japanese Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.12 The Brazilian Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%),
2013-2024
Table 7.13 The Russian Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.14 The Indian Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.15 The Chinese Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.16 The South Korean Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.17 The Mexican Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 8.1 Alcon: Revenue ($m), AGR (%) by Segment, 2011-2013
Table 8.2 Alcon Surgical Segment: Revenue ($m), AGR (%) by Subsegment, 2012-2013
Table 8.3 Alcon Vision Care Segment: Revenue ($m), AGR (%) by Subsegment, 2012-2013
Table 8.4 Abbott Medical Devices: Revenue ($m), AGR (%) by Segment, 2012-2013
Table 8.5 Abbott Medical Devices: Product Line, 2014
Table 8.6 Bausch and Lomb: Revenue ($m), AGR (%), 2008-2012
Table 8.7 Bausch and Lomb: Revenue ($m), AGR (%) by Segment, 2010-2012
Table 8.8 J&J Medical Devices and Diagnostics: Revenue ($bn), Revenue Share (%) by Segment, 2013
Table 8.9 J&J Vision Care: Revenue ($m), AGR (%), 2011-2013
Table 8.10 J&J Vision Care: Product Line by Wear Time, 2014
Table 8.11 J&J Vision Care: Product Line by Type of Refractive Error, 2014
Table 8.12 Nidek: Revenue ($m), AGR (%), CAGR (%), 2008-2012
Table 8.13 Hoya: Revenue ($m), AGR (%), CAGR (%), 2007-2013
Table 8.14 STAAR: Revenue ($m), AGR (%), CAGR (%), 2009-2013
Table 8.15 STAAR: Revenue ($m), Revenue Share (%) by Region, 2013
Table 8.16 STAAR: Revenue ($m), AGR (%) by Segment, 2011-2013
Table 8.17 STAAR: Product line
Table 8.18 Carl Zeiss Meditec: Revenue ($m), AGR (%), 2012-2013
Table 8.19 Carl Zeiss Meditec: Revenue ($m), AGR (%) by Business Unit, 2012-2013
Table 8.20 Carl Zeiss Meditec: Revenue ($m), Revenue Share (%) by Region, 2013
Table 8.21 Carl Zeiss Meditec: Ophthalmic Product Line
Table 8.22 TopCon: Revenue ($m), Revenue Share (%) by Company, 2013
Table 8.23 Haag-Streit: Medical Technology & Specialities

【レポートのキーワード】

医療機器、眼科装置、眼科ビジョンケア装置、眼科診断・モニタリング装置、眼科手術装置

★調査レポート[世界の眼科装置市場予測:眼科ビジョンケア装置、眼科診断・モニタリング装置、眼科手術装置] ( Ophthalmic Devices Market Forecast 2014-2024
Future Prospects for Leading Companies / VISG409053) 販売に関する免責事項
[世界の眼科装置市場予測:眼科ビジョンケア装置、眼科診断・モニタリング装置、眼科手術装置] ( Ophthalmic Devices Market Forecast 2014-2024
Future Prospects for Leading Companies / VISG409053) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆